Top 10 investors in Western Europe with the biggest sum of Private Equity funding rounds in Biotechnology industry over the recent years

Top 10 investors in Western Europe with the biggest sum of Private Equity funding rounds in Biotechnology industry over the recent years

Intro

The top 10 investors according to the total money raised in the funding rounds. These are VC funds and corporate investors in Western Europe that have invested in Private Equity stage over the last 2 years. They are actively investing in Biotechnology industry.
Biotechnology is the use of biology to make or develop products. It includes biopharmaceutical, genetics, and neuroscience.

Amount of money raised in Biotechnology funding rounds is $964.7M, which is 5.2% of the total amount of money raised in Private Equity rounds in Western Europe over the last 2 years.

Top 10 investors in Western Europe with the biggest sum of Private Equity funding rounds in Biotechnology industry over the recent years
data provided by Unicorn Nest

Save this chart to use it in your presentation
Download the diagram

Key takeaways

  • Funds Geography – The most common countries among top VCs are The United Kingdom and Switzerland. They host 3 VCs each. There are also funds from Sweden and Norway. All funds are based in different cities. No city grouping tendencies were found in this sample. VCs tend to invest in startups from The United States, but also invest in startups from The United Kingdom, Switzerland, and Ireland. For 4 funds in the sample, the country of the funds’ establishment and the country of their most frequent investments coincide.
  • Industry Focus – The funds’ most common field for investments is Finance. They also invest in Medical Service, Bio & Nano Technology and Business Development.
  • Important Years – The oldest fund in the sample was founded in 1972 and the newest one in 2014. In 2008 the most amount of funds were founded. VCs in the sample made the most deals in the period from 2009 to 2020. For some funds, 2020 was the year with the most amount of deals. The biggest amount of successful exits happened between 2009 and 2021 years. For some funds, 2020 became the year with the most successful exits.
  • Investments – Usually VCs take part in 2 – 6 funding rounds per year, sometimes in 2. The minimum number of funding rounds for VCs in the sample is 11, the maximum is 232. Average number of funding rounds is 74.3 while median is 49.0. The most common amount of funding rounds for VCs in the sample is 49. Minimum amount of lead investments for funds is 0 and maximum is 83. Average amount of lead investments is 22.9 while median is 9.0. The most common amount of lead investments is 6. Index of difference in percentage points of lead investments from the average is between -39.75 and 29.0 for funds in the sample. The average value for this difference is -1.11 and the median is -1.14. It means that these funds act as lead investors less often than other funds.
  • Typical Rounds – No grouping tendencies in the amount of investors in the funding rounds were found in this sample. The most common round size for VCs in the sample is 50 – 100 million. Less common range is 10 – 50 million. A Funds’ average multiplicator for portfolio companies at the last known valuation is 0.07 at minimum and 19.2 at maximum. Average value for this multiplicator is 5.19 and median is 3.82.
Biotechnology Private Equity Western Europe
Looking for investments?
We help you to get a list of investors based on your personal choice
Crunchbase icon

Content report

The following text will be sent to our editors: